Emergent BioSolutions
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Emergent BioSolutions's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 6% to $1,049,300,000. Profit margin reached -72%. Total operating expenses were $1,044,000,000.
Profit Margin
| 2014 | 450.13M | 36.74M | 8.16% |
|---|---|---|---|
| 2015 | 522.78M | 62.87M | 12.03% |
| 2016 | 488.78M | 51.77M | 10.59% |
| 2017 | 560.87M | 82.59M | 14.73% |
| 2018 | 782.4M | 62.7M | 8.01% |
| 2019 | 1.10B | 54.5M | 4.93% |
| 2020 | 1.55B | 305.8M | 19.66% |
| 2021 | 1.79B | 219.5M | 12.24% |
| 2022 | 1.12B | -223.8M | -19.97% |
| 2023 | 1.04B | -760.5M | -72.48% |
EBS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.04B | 1.12B | 1.79B | 1.55B | 1.10B | 782.4M | 560.87M | 488.78M | 522.78M | 450.13M |
Cost of revenue | 705.4M | 693.7M | 757.5M | 524M | 433.5M | 322.3M | 195.70M | 131.28M | 124.29M | 118.41M |
Gross profit | 343.9M | 427.2M | 1.03B | 1.03B | 672.5M | 460.1M | 365.16M | 357.49M | 398.49M | 331.72M |
Operating exp. | ||||||||||
Research and development | 111.4M | 193M | 234M | 234.5M | 226.2M | 142.8M | 97.38M | 108.29M | 153.99M | 150.82M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.04B | 593.2M | 640.9M | 597.6M | 558.4M | 370.3M | 240.88M | 251.97M | 302.45M | 273.67M |
Operating income | -726.4M | -166M | 352.6M | 433.8M | 114.1M | 89.8M | 124.28M | 105.52M | 96.03M | 58.05M |
Other income (expenses), net | -4.8M | -55.7M | -38.2M | -26.6M | -36.7M | 1.6M | -5.7M | 263K | -5.79M | -4.99M |
Income before tax | -731.2M | -221.7M | 314.4M | 407.2M | 77.4M | 81.5M | 118.63M | 99.22M | 89.76M | 53.06M |
Income tax expense | 29.3M | 2.1M | 83.5M | 102.1M | 22.9M | 18.8M | 36.03M | 36.69M | 26.89M | 16.32M |
Net income | -760.5M | -223.8M | 219.5M | 305.8M | 54.5M | 62.7M | 82.59M | 51.77M | 62.87M | 36.74M |
Earnings per share | ||||||||||
Basic EPS | -14.85 | -4.47 | 4.1 | 5.79 | 1.06 | 1.25 | 1.98 | 1.29 | 1.63 | 0.98 |
Diluted EPS | -14.85 | -4.47 | 4.06 | 5.67 | 1.04 | 1.22 | 1.71 | 1.13 | 1.41 | 0.88 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |